Key Takeaways:
- Shares opened at $35.5, a 76.6 percent premium to the listing price.
- The company's stock was priced at $20.1 for its initial public offering.
- The debut follows a 60 percent gain in gray market trading on the prior day.
Back
Impact Therapeutics stock debuts with a 77% surge to $35.5
Impact Therapeutics (07630.HK) surged 76.6 percent in its Hong Kong trading debut, opening at $35.5 after a strong performance in pre-market trading.
The biopharmaceutical company’s offering was priced at $20.1 per share. The debut reflects significant investor interest, with 7.93 million shares changing hands at the market open.
The stock’s strong opening follows a notable performance on the gray market, where it closed at $32.16 on the previous day, a 60 percent increase from its listing price.
The successful listing provides the company with fresh capital to advance its pipeline of therapeutic candidates. The strong reception will be a key test of investor appetite for biopharmaceutical IPOs in the Hong Kong market.
This article is for informational purposes only and does not constitute investment advice.
